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Occupational Reproductive Function Abnormalities and Bladder 
Cancer in Korea  
The purpose of this study was to review occupational reproductive abnormalities and 
occupational bladder cancer in Korea and to discuss their toxicological implications. 
Reproductive dysfunction as a result of 2-bromopropane poisoning was first reported in 
Korean workers. In 1995, 23 of the 33 workers (25 female and 8 male workers) who were 
exposed to 2-bromopropane during the assembly of tactile switch parts developed 
reproductive and/or hematopoietic disorders. A total of 17 (68%) workers were diagnosed 
with ovarian failure. Two of the eight male workers experienced azoospermia and four 
workers experienced some degree of oligospermia or reduced sperm motility. In summary, 
2-bromopropane poisoning caused severe reproductive effects in Korean workers. The 
prognosis was poor for reproductive dysfunction. A few cases of occupational bladder 
cancer have been reported in Korea, whereas other cancers of the urinary tract have not 
been reported after occupational exposure. A few cases of benzidine-induced cancer have 
been reported in Korea and 592 workers in Japan have received compensation for 
benzidine and β-naphthylamine-induced cancer. In conclusion, a few cases of benzidine-
induced occupational bladder cancer have been reported in Korea. However, benzidine-
induced bladder cancer will likely be an important occupational health issue in Korea in the 
coming years.
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INTRODUCTION
According to the United States Environmental Protection Agen-
cy, more than 65,000 commercial chemicals are currently used 
in the USA and 2,000 to 3,000 new chemicals are added each 
year (1). Historically, Korea has depended on Japan for eco-
nomic development. Korea has experienced rapid economic 
development since the 1960s, a phenomenon that has caused 
the Korean economy to shift from labor-intensive (i.e., light) in-
dustries to machinery-intensive (i.e., heavy) industries such as 
automobile, petrochemical, shipbuilding, non-ferrous metal, 
machinery and semi-conductor industries. Many toxic chemi-
cals are widely used in these industries. New chemicals and in-
dustries have occasionally been transferred to Korea from Ja-
pan (2). 
  The purpose of this study was 1) to review the outbreak and 
the progress of 2-bromopropane-induced reproductive abnor-
malities in Korea and to discuss their toxicological implications; 
2) to review cases of benzidine-induced occupational bladder 
cancer in Korea and to discuss their toxicological implications 
compared to those in Japan. 
MATERIALS AND METHODS
We conducted an extensive search of the PubMed and Korea- 
Med databases for studies of urinary tract cancer and repro-
ductive abnormalities in Korea that were published through 
December 2009 and we evaluated all relevant papers and their 
references published in Korean and English. In addition, we 
conducted a thorough review of the electronic database on oc-
cupational diseases maintained by the Korea Workers’ Com-
pensation and Welfare Service.
 
RESULTS AND DISCUSSION
Occupational Reproductive Function Abnormalities
Reproductive effects in humans are usually assessed according 
to observable outcomes in men (e.g., reduced sperm produc-
tion, impotence, infertility) and women (e.g., acyclicity, delayed 
time to conception, early menopause, or pregnancy outcome). 
Generally, the identification of reproductive effects in humans 
is a slow process because it relies on population-based and clin-
ical observations (3). Park J, et al.  •  Occupational Reproductive Function Abnormalities and Bladder Cancer
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  Exposure to specific chemicals can cause reversible or irre-
versible damage to fertility. Only a few substances have been 
shown to influence fertility in occupational medicine, specifi-
cally, lead, organic mercury compounds, manganese, carbon 
disulfide, 2-bromopropane, glycol ethers (e.g., 2-ethoxyethanol, 
2-ethoxyethanol acetate, 2-methoxyethanol and 2-methoxy-
ethanol acetate) and dibromochloropropane (DBCP) (4). Re-
productive dysfunction as a result of 2-bromopropane poison-
ing was first reported in Korean workers. However, there have 
been no reported cases of reproductive abnormalities in Korea 
due to any other agent. 
2-Bromopropane poisoning
2-Bromopropane was used by an electronic parts manufactur-
ing company in Korea. In 1995, 33 workers (8 male and 25 female 
workers) were exposed to 2-bromopropane during the assem-
bly of tactile switch parts, and, 23 workers (17 female and 6 male 
workers) of them developed reproductive and/or hematopoiet-
ic disorders, whereas none experienced adverse health effects 
in any other work process in the same factory (5, 6). Seventeen 
(68%) female workers developed secondary amenorrhea for var-
ious periods (2-14 months). 
  In the clinical interviews and examinations performed by the 
Occupational Safety and Health Research Institute (OSHRI), 
they were found to have had normal menstruation up to this 
outbreak, and they had not used any special medication or the 
pill during their time on the job. They were diagnosed with ovar-
ian failure. These workers showed high follicle-stimulating hor-
mone levels, normal prolactin levels, decreased estrogen levels 
and hot flashes. The other eight female workers had no health ef-
fects. A total of eight workers with amenorrhea concurrently 
developed pancytopenia. Two of the eight male workers expe-
rienced azoospermia and four workers experienced some degree 
of oligospermia or reduced sperm motility, whereas the other 
two male workers had no health effects. Effects on the testes and 
ovaries, and the bone marrow were the main health hazards en-
countered in this workplace. 
  In the tactile switch assembly process, all of workers with the 
health effects had been working since 2-bromopropane had 
been introduced into the process, whereas former workers who 
quitted the process before 2-bromopropane was used in the pro-
cess had no health effects. The health effects were also shown 
in workers who worked for more than  1 yr in the process. With 
the exception of a cleaning solution that contained 97.4% 2-bro-
mopropane, no other physical or chemical agents could be 
blamed for the gonadal and bone marrow effects; for example, 
there was no exposure to ionizing radiation, lead, ethylene gly-
col ether and its acetates, benzene and 1,2-dibromo-3-chloro-
propane (DBCP) (5, 6). Simulation studies showed that the work-
ers might have been occasionally exposed to several thousand 
ppm for a short time during manipulation of the cleaning baths, 
although the measured ambient concentration of 2-bromopro-
pane after the facilities were improved was 12.4±3.13 (mean±SD, 
range 9.2-19.6) ppm (5, 6). It should be noted that the chemical 
structure of 2-bromopropane is similar to that of DBCP, which 
can cause male infertility and bone marrow depression (7, 8). 
In the epidemiological survey, the authors concluded that 2- 
bromopropane, as an alkylating agent, might inhibit the rapidly 
proliferating cells such as hematopoietic cells or germ cells with-
in the testis or ovary, although the alleged reproductive and he-
matopoietic effects of this chemical had not yet been demon-
strated in animal studies before the outbreak. This was the first 
report of toxicity due to 2-bromopropane. 2-Bromopropane 
poisoning was a typical example of human reproductive effects 
being linked to exposure before a causal relationship was dem-
onstrated in animals.
  Histopathological examination of biopsies obtained from four 
of the female factory workers with secondary amenorrhea showed 
focal or diffuse fibrosis of the ovarian cortex, disappearance of 
follicles at various stages of development and low numbers of 
primary follicles and corpus albicans (9). Histopathological ex-
amination of biopsies obtained from six of the male workers 
with reproductive dysfunction showed atrophy of the seminif-
erous tubules, thickening of the basement membrane and hy-
perplasia of Leydig cells (10). Since the outbreak numerous ani-
mal studies also have confirmed that 2-bromopropane is toxic 
to reproductive organs and hematopoietic tissues, as found in 
Korean workers (11-19). The prognosis was poor for affected 
reproductive function but good for affected hematopoietic func-
tion. Ten of the 17 female workers with ovarian failure experi-
enced spontaneous menstruation after approximately 40 months 
of amenorrhea (20). A female worker of them became pregnant 
and gave birth to a normal full-term baby who was healthy at 
the 6 month check-up (9, 20). However, this single case provides 
insufficient data to fully evaluate the developmental toxicity of 
2-bromopropane. Five male workers completely recovered from 
reproductive dysfunction after 2 yr’ cessation of exposure to 2- 
bromopropane, however, one worker failed to recover complete-
ly even after 6 yr’ cessation of exposure (10). However, all workers 
recovered from hematopoietic dysfunction. The company even-
tually closed due to financial reasons and no other cases of 2- 
bromopropane poisoning have been reported.
  2-Bromopropane was developed as a non-hazardous substi-
tute for chlorofluorocarbons, which damage the stratospheric 
ozone layer. This chemical is more expensive than chlorofluo-
rocarbons and was imported to Korea in 1994 from an affiliated 
Japanese company for use as a cleaning solution (6). Japanese 
workers used 2-bromopropane in a similar process for several 
years while wearing standard protective personal devices and 
significant health effects were not reported until the outbreak 
described here. At the time, toxicological data were not available 
for this chemical and no occupational standards had been de-Park J, et al.  •  Occupational Reproductive Function Abnormalities and Bladder Cancer
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veloped (21). Thus, both management staff and workers were 
under the false impression that 2-bromopropane was safe and 
neither group implemented any safety precautions in Korea. 
The Korean company might have prevented the outbreak by 
assuming that the new chemical was toxic even though it did 
not have any established toxicities at the time. After the outbreak, 
we reviewed the periodic medical records of Japanese workers 
exposed to 2-bromopropane and found that mild anemia, which 
went unnoticed by medical personnel, had occurred in three 
workers (2). In addition, Ichihara et al. (22) found a possible as-
sociation between hematological indices and individual expo-
sure to 2-bromopropane in workers at a Chinese factory that 
produced the chemical, although they did not observe cases of 
severe reproductive toxicity similar to those seen in the Korean 
workers. The authors showed that the Chinese workers were ex-
posed to less than 10 ppm (TWA). 
  When the two surveys in Japan and China were taken togeth-
er with Korean outbreak, it seemed that high doses of 2-bromo-
propane caused severe reproductive and hematopoietic effects 
in most Korean workers whereas low doses of 2-bromopropane 
caused mild anemia only in some Japanese and Chinese work-
ers. These were consistent with the findings that prognosis was 
poor for affected reproductive function but good for affected 
hematopoietic function in Korean workers exposed to 2-bro-
mopropane. This highlights a fundamental principle of toxicol-
ogy: the dose makes the poison. In summary, 2-bromopropane 
poisoning causes severe reproductive effects in Korean work-
ers. The prognosis is poor for reproductive dysfunction.
 
Occupational Bladder Cancer 
Bladder cancer is the most common cancer of the urinary tract 
and is the eleventh most common cancer in the world (23). Be-
tween 5% and 25% of all cases of bladder cancer can be attrib-
uted to the workplace (24). Therefore, if a patient presents with 
bladder cancer, a detailed history of occupation and exposure to 
bladder carcinogens should be obtained. The only major non-
occupational risk factor for bladder cancer is cigarette smoking. 
A few cases of benzidine-induced occupational bladder cancer 
have been reported in Korea, whereas other types of urinary 
tract cancer have not been reported. 
 
Benzidine-induced bladder cancer 
The history of dye industry in Korea is closely related with that 
in Japan. Korean dye manufacturing industry implemented 
Japanese techniques and significantly expanded when the Jap-
anese government banned the manufacture and use of potent 
bladder carcinogens (such as β-naphthy  lamine and benzidine). 
Korea subsequently began exporting benzidine dyes to several 
countries, mainly Japan (2). In Korea, the decision in 1980 to sus-
pend the production of benzidine and benzidine-based dyes 
was deferred owing to the importance of the dye industry in 
Korea. In the 1990s, there were one factory manufacturing ben-
zidine illegally and also manufacturing benzidine chlorides and 
eight factories using benzidine chlorides in Korea. Korea finally 
prohibited the production of benzidine-based dyes and benzi-
dine dichlorides in 2000 (25). To date, a few cases of benzidine-
induced cancer have been reported in Korea. The authors in-
vestigated the incidence of bladder cancer in Korea in 1999 and 
early 2006 among 650 workers who were employed at represen-
tative factories that manufactured and handled benzidine-based 
dyes. We identified two individuals with bladder cancer by 
searching the Korean National Cancer Registry database and 
records of compensation claims for occupational diseases. The 
latency periods for these patients were estimated as 30 yr and 
36 yr, respectively. The relatively low incidence of bladder can-
cer among these workers and the relatively longer latency peri-
ods for these two patients indicate that the Korean workers 
were exposed to relatively low levels of benzidine than were the 
Japanese workers (25). 
  One additional male worker was diagnosed with occupation-
al bladder cancer after 17 yr of exposure to dyestuffs containing 
benzidine-based dyes in a dyeing factory (26). Some studies have 
suggested that the risk of bladder cancer differs after exposure 
to benzidine or benzidine dihydrochloride versus exposure to 
benzidine dyes. For example, Tsuchiya et al. (27) found that the 
incidence rate of bladder cancer reached 11.3% among mem-
bers of a benzidine manufacturing group, whereas the incidence 
of bladder cancer reached only 1.4% among the benzidine dyes 
manufacturing group. According to a study by You et al. (28), 
workers have a significantly higher risk of bladder cancer dur-
ing the first part of the dyestuff synthesis process when they are 
directly exposed to benzidine. In contrast, the risk of bladder 
cancer is lower during the latter part of the dyestuff synthesis 
process, after the benzidine-based dyestuff has been synthe-
sized, and textile dye workers. However, it is not clear why the 
latency period was shorter in this case than in the two other 
workers with bladder cancer. 
  Nishimura reported the first four cases of bladder cancers in 
dye workers in Japan (29) and more than 30 patients with blad-
der cancer were identified by the end of 1961. Beginning in 1962, 
the Japanese dyestuff industries teamed with university research-
ers and used urinary cytology examinations to detect bladder 
cancer in dye workers (30). By 1972, more than 120 dye workers 
had been diagnosed with bladder cancer. That same year, the 
Industrial Safety and Health Law prohibited the manufacture of 
benzidine, β-naphthylamine and their salts in Japan (30). This 
law also required government permission for the production of 
dichlorobenzidine and its salts. However, the import and use of 
benzidine dyes was permitted, provided the benzidine content 
did not exceed 1% (31). Replacement dyes that matched the ben-
zidine dyes in both price and technical properties were not avail-
able, which spawned a continued, albeit declining, demand for Park J, et al.  •  Occupational Reproductive Function Abnormalities and Bladder Cancer
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benzidine dyes. This demand was met by manufacturers out-
side of Japan, particularly those in Korea. The technologies used 
to manufacture benzidine dyes were transferred to Korea from 
Japan around the same time that benzidine was prohibited in 
Japan. To date, 592 workers in Japan have received compensa-
tion for benzidine-induced and β-naphthylamine-induced can-
cers (32). 
  The marked differences in the development of occupational 
bladder cancer in Korea and Japan may reflect differences in 
exposure levels and patterns between the two countries. Expo-
sure was much greater in the Japanese dye industry than in the 
Korean industry. There were also differences in the raw materi-
als used to manufacture benzidine-based dyes between the two 
countries. Free benzidine base was used in Japan, but benzidine 
chloride was used in Korea. Benzidine base crumbles easily and 
can readily disperse in the air; however, if wet-caked as benzi-
dine chloride, its ability to disperse is markedly decreased. This 
difference may have reduced workers’ exposure levels (25). 
  In summary, a few cases of benzidine-induced occupational 
bladder cancer have been reported in Korea. However, benzi-
dine-induced bladder cancer will likely be an important occu-
pational health issue in Korea in the coming years, despite the 
relatively low incidence and longer latency period of cancer in 
Korea. 
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